These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. A simplified algorithm for the laboratory detection of lupus anticoagulants: utilization of two automated integrated tests. Zhang L; Whitis JG; Embry MB; Hollensead SC Am J Clin Pathol; 2005 Dec; 124(6):894-901. PubMed ID: 16416739 [TBL] [Abstract][Full Text] [Related]
26. Reference interval mean clotting times should not be used to calculate lupus anticoagulant mixing test ratios unless they match the normal pooled plasma clotting time. Moore GW Thromb Res; 2017 Nov; 159():16-18. PubMed ID: 28946004 [No Abstract] [Full Text] [Related]
28. [Notes on laboratory coagulation testing for acquired hemophilia A]. Amano K Rinsho Byori; 2009 Oct; 57(10):999-1003. PubMed ID: 19928498 [TBL] [Abstract][Full Text] [Related]
29. Detection of the lupus anticoagulant in pregnancy. Derksen RH; Out HJ; Blokzijl L; de Groot PG Clin Exp Rheumatol; 1992; 10(3):323-4. PubMed ID: 1582083 [No Abstract] [Full Text] [Related]
30. Testing for lupus anticoagulants: all that a clinician should know. Tripodi A Lupus; 2009 Apr; 18(4):291-8. PubMed ID: 19276296 [TBL] [Abstract][Full Text] [Related]
31. Detection of unexpected lupus anticoagulant during preparation of normal pooled plasma (NPP) from healthy volunteers. Ghosh K; Shetty S; Mohanty D Thromb Haemost; 2000 Sep; 84(3):519-21. PubMed ID: 11019985 [No Abstract] [Full Text] [Related]
32. Is there evidence for persistent or transient positive lupus anticoagulants according to the degree of prolongation of clotting tests? Devreese KM Thromb Res; 2008; 122(4):576-9. PubMed ID: 18304615 [No Abstract] [Full Text] [Related]
33. The tissue thromboplastin inhibition test in the detection of lupus anticoagulants: importance of a correction factor eliminating the influence of fibrinogen level. Eschwège V; Seddiki S; Robert A Thromb Haemost; 1996 Jul; 76(1):65-8. PubMed ID: 8819253 [TBL] [Abstract][Full Text] [Related]
34. Lupus anticoagulant assays: questions answered and to be answered. Teruya J; West AG; Suell MN Arch Pathol Lab Med; 2007 Jun; 131(6):885-9. PubMed ID: 17550315 [TBL] [Abstract][Full Text] [Related]
35. Thromboelastography assessment of coagulation status in parturients with lupus anticoagulant receiving heparin therapy. Harnett M; Kodali BS Int J Obstet Anesth; 2006 Apr; 15(2):177-8. PubMed ID: 16488131 [No Abstract] [Full Text] [Related]
37. Significance of antiphospholipid antibodies in lupus nephritis. Natejumnong C; Ruangkanchanasetr P; Aimpun P; Supaporn T J Med Assoc Thai; 2006 Aug; 89 Suppl 2():S121-8. PubMed ID: 17044463 [TBL] [Abstract][Full Text] [Related]
38. Detection of low levels of lupus anticoagulant antibodies. Villa P; Mira Y; Ferrando F; Vayá A; Aznar J Thromb Res; 2005; 116(5):447-9. PubMed ID: 15925399 [No Abstract] [Full Text] [Related]
39. Inhibitor Index in the Clot Waveform Analysis-Based Mixing Test Differentiates among Hemophilia A without and with Inhibitors, and Lupus Anticoagulant. Shimonishi N; Ogiwara K; Oda Y; Kawabe T; Emmi M; Shima M; Nogami K Thromb Haemost; 2021 Jun; 121(6):792-799. PubMed ID: 33412612 [TBL] [Abstract][Full Text] [Related]
40. To do or not to do mixing study in the era of integrated testing for lupus anticoagulant. Ray D; Ahluwalia J; Hans C; Kler A; Kumar A; Kumar N Blood Coagul Fibrinolysis; 2024 Jun; 35(4):223-224. PubMed ID: 38709110 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]